Molecular Partners AG
F:6ML
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Molecular Partners AG
F:6ML
|
CH |
|
M
|
Montage Gold Corp
OTC:MAUTF
|
CA |
|
Capstone Therapeutics Corp
OTC:CAPS
|
US |
|
M
|
Mundoro Capital Inc
XMUN:NGU
|
CA |
|
URZ3 Energy Corp
OTC:URZEF
|
CA |
|
S
|
SNU Precision Co Ltd
KOSDAQ:080000
|
KR |
|
M
|
Matsa Resources Ltd
XMUN:KB2
|
AU |
|
W
|
Wolford AG
XMUN:WOF
|
AT |
|
K
|
Kratos Defense and Security Solutions Inc
LSE:0JS0
|
US |
|
S
|
SkyWest Inc
F:SY2
|
US |
|
C
|
Columbus Circle Capital I Corp
NASDAQ:CCCM
|
US |
|
ANBC Inc
OTC:SYUP
|
US |
|
Nordic Mining ASA
OSE:NOM
|
NO |
|
G
|
Games Operators SA
F:8P7
|
PL |
|
Beyondspring Inc
NASDAQ:BYSI
|
US |
|
E
|
Eline Entertainment Group Inc
OTC:EEGI
|
US |
|
A
|
ALBA SE
XHAM:ABA
|
DE |
|
Bhakti Agung Propertindo Tbk PT
IDX:BAPI
|
ID |
|
Schrole Group Ltd
ASX:SCL
|
AU |
|
Lucky Minerals Inc
F:LKY1
|
CA |
|
H
|
HPI AG
XMUN:CEW3
|
DE |
|
Affinor Growers Inc
F:1AF
|
CA |
|
International Petroleum Corp
F:IPT
|
CA |
|
S
|
SpectraCure AB (publ)
STO:SPEC
|
SE |
Bankruptcy Probability
Molecular Partners AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Molecular Partners AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
|
Molecular Partners AG
SIX:MOLN
|
121.2m CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
226.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
65.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Molecular Partners AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Molecular Partners AG has total debt of 2.1m CHF. This includes both short-term (0 CHF) and long-term (2.1m CHF) debt.
You can find a full breakdown on its Balance Sheet.
